Evaluation of recurrent ventricular tachyarrhythmias in patients who survived out-of-hospital cardiac arrest due to ventricular fibrillation: eligibility for subcutaneous implantable defibrillator therapy-Reference-Cited by-同舟云学术

Evaluation of recurrent ventricular tachyarrhythmias in patients who survived out-of-hospital cardiac arrest due to ventricular fibrillation: eligibility for subcutaneous implantable defibrillator therapy

Published:2018-11-26 Issue:3 Volume:55 Page:317-323
ISSN:1383-875X
Container-title:Journal of Interventional Cardiac Electrophysiology
language:en
Short-container-title:J Interv Card Electrophysiol

Author:

Theuns Dominic A. M. J.^ORCID,Bhagwandien Rohit E.,Szili-Torok Tamas,Zijlstra Felix,Yap Sing-Chien

Funder

University Medical Center Rotterdam

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10840-018-0490-4.pdf

Reference25 articles.

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576–83.

2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297–302.

3. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21:2071–8.

4. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748–54.

5. Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M, et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2013;61:1318–68.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indications and effectiveness of ICD for primary and secondary prevention in patients admitted in Ahvaz Imam Khomeini Hospital since 2017;Advanced Biomedical Research;2023

2. Atrial Fibrillation and Ventricular Tachyarrhythmias: Advancements for Better Outcomes;Cardiovascular & Hematological Disorders-Drug Targets;2021-01-13

3. How to minimize peri-procedural complications during subcutaneous defibrillator implant?;Expert Review of Cardiovascular Therapy;2020-07-02

4. Effect of Implantable Cardioverter-defibrillator Therapy for Ventricular Fibrillation Patients with Out-of-hospital Cardiac Arrest;The Showa University Journal of Medical Sciences;2020

5. Spotlight on S-ICD™ therapy: 10 years of clinical experience and innovation;EP Europace;2019-03-18